Technology
Health
Pharmaceutical
Odonate Therapeutics
$33.179876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$33.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.06%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ODT and other stocks, options, ETFs, and crypto commission-free!
About ODT
Odonate Therapeutics, Inc. Common Stock, also called Odonate Therapeutics, is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. Read More It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
Employees
130
Headquarters
San Diego, California
Founded
2013
Market Cap
887.38M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
154.13K
High Today
$33.33
Low Today
$32.12
Open Price
$32.91
Volume
121.02K
52 Week High
$37.99
52 Week Low
$11.54
Collections
Technology
Health
Pharmaceutical
Therapy
Cancer Prevention
2017 IPO
US
North America
Price Paid on Robinhood
70% Higher
Right Now
52 Week Low
$11.54
Average Price Paid
$19.54
52 Week High
$28.57
ODT Earnings
-$1.24
-$1.09
-$0.94
-$0.79
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 25, Pre-Market